1. Using magnetic resonance imaging (MRI), we demonstrated atrophy of the corpus callosum, a marker of neocortical neuronal loss, in nondemented Down syndrome (trisomy 21) adults compared with age-matched healthy controls. Down syndrome subjects are at risk for Alzheimer disease, due to duplication of the amyloid precursor protein (APP) gene on chromosome 21. Measuring corpus callosum volume with MRI could help to identify subjects in the general population with mild cognitive insufficiency who later will develop Alzheimer disease. 2. Automated voxel-based morphometry was used to analyze structural magnetic resonance images of brains from 27 non-demented Down syndrome adults, an at-risk group for Alzheimer disease, of different ages. In this group, grey matter volume declined with advancing age in numerous cortical regions, suggesting that brain atrophy occurs and progresses before clinical dementia becomes evident in Down syndrome.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Intramural Research (Z01)
Project #
1Z01AG000132-20
Application #
6968657
Study Section
(BPMS)
Project Start
Project End
Budget Start
Budget End
Support Year
20
Fiscal Year
2004
Total Cost
Indirect Cost
Name
Aging
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Teipel, Stefan J; Alexander, Gene E; Schapiro, Marc B et al. (2004) Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry. Brain 127:811-24
Teipel, Stefan J; Schapiro, Mark B; Alexander, Gene E et al. (2003) Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome. Am J Psychiatry 160:1870-8
Cardenas, Ana Maria; Arriagada, Christian; Allen, David D et al. (2002) Cell lines derived from hippocampal neurons of the normal and trisomy 16 mouse fetus (a model for Down syndrome) exhibit neuronal markers, cholinergic function, and functional neurotransmitter receptors. Exp Neurol 177:159-70
Cardenas, Ana Maria; Allen, David D; Arriagada, Christian et al. (2002) Establishment and characterization of immortalized neuronal cell lines derived from the spinal cord of normal and trisomy 16 fetal mice, an animal model of Down syndrome. J Neurosci Res 68:46-58
Allen, David D; Cardenas, Ana Maria; Arriagada, Christian et al. (2002) A dorsal root ganglia cell line derived from trisomy 16 fetal mice, a model for Down syndrome. Neuroreport 13:491-6
Galdzicki, Z; Siarey, R; Pearce, R et al. (2001) On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models. Brain Res Brain Res Rev 35:115-45
Klein, R C; Siarey, R J; Caruso, A et al. (2001) Increased expression of NR2A subunit does not alter NMDA-evoked responses in cultured fetal trisomy 16 mouse hippocampal neurons. J Neurochem 76:1663-9
Murphy, E J; Schapiro, M B; Rapoport, S I et al. (2000) Phospholipid composition and levels are altered in Down syndrome brain. Brain Res 867:18-Sep
Peng, S; Rapoport, S I; Pearce, R J et al. (2000) Abnormal chloride and potassium conductances in cultured embryonic tongue muscle from trisomy 16 mouse. Brain Res Dev Brain Res 122:193-7
Shetty, H U; Siarey, R J; Galdzicki, Z et al. (2000) Ts65Dn mouse, a Down syndrome model, exhibits elevated myo-inositol in selected brain regions and peripheral tissues. Neurochem Res 25:431-5

Showing the most recent 10 out of 12 publications